133 related articles for article (PubMed ID: 9370342)
1. Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes.
Maser E; Oppermann UC
Eur J Biochem; 1997 Oct; 249(2):365-9. PubMed ID: 9370342
[TBL] [Abstract][Full Text] [Related]
2. Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen.
Maser E; Friebertshäuser J; Völker B
Chem Biol Interact; 2003 Feb; 143-144():435-48. PubMed ID: 12604230
[TBL] [Abstract][Full Text] [Related]
3. 11Beta-hydroxysteroid dehydrogenase type 1: purification from human liver and characterization as carbonyl reductase of xenobiotics.
Maser E; Wsol V; Martin HJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):34-7. PubMed ID: 16343739
[TBL] [Abstract][Full Text] [Related]
4. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung.
Finckh C; Atalla A; Nagel G; Stinner B; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):761-73. PubMed ID: 11306092
[TBL] [Abstract][Full Text] [Related]
5. 11Beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes.
Maser E
Cancer Res; 1998 Jul; 58(14):2996-3003. PubMed ID: 9679962
[TBL] [Abstract][Full Text] [Related]
6. Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: recombinant expression in the yeast Pichia pastoris and Escherichia coli.
Blum A; Martin HJ; Maser E
Toxicology; 2000 Apr; 144(1-3):113-20. PubMed ID: 10781878
[TBL] [Abstract][Full Text] [Related]
7. Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung.
Maser E; Stinner B; Atalla A
Cancer Lett; 2000 Feb; 148(2):135-44. PubMed ID: 10695989
[TBL] [Abstract][Full Text] [Related]
8. Human microsomal carbonyl reducing enzymes in the metabolism of xenobiotics: well-known and promising members of the SDR superfamily.
Skarydová L; Wsól V
Drug Metab Rev; 2012 May; 44(2):173-91. PubMed ID: 22181347
[TBL] [Abstract][Full Text] [Related]
9. Characterization of enzymes participating in carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human placenta.
Atalla A; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):737-48. PubMed ID: 11306090
[TBL] [Abstract][Full Text] [Related]
10. Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily.
Hoffmann F; Maser E
Drug Metab Rev; 2007; 39(1):87-144. PubMed ID: 17364882
[TBL] [Abstract][Full Text] [Related]
11. Biochemical properties of human dehydrogenase/reductase (SDR family) member 7.
Stambergova H; Skarydova L; Dunford JE; Wsol V
Chem Biol Interact; 2014 Jan; 207():52-7. PubMed ID: 24246760
[TBL] [Abstract][Full Text] [Related]
12. 11 beta-hydroxysteroid dehydrogenase mediates reductive metabolism of xenobiotic carbonyl compounds.
Maser E; Bannenberg G
Biochem Pharmacol; 1994 May; 47(10):1805-12. PubMed ID: 8204097
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation and detoxification of insecticidal metyrapone analogues by carbonyl reduction in the human liver.
Rekka EA; Soldan M; Belai I; Netter KJ; Maser E
Xenobiotica; 1996 Dec; 26(12):1221-9. PubMed ID: 9004452
[TBL] [Abstract][Full Text] [Related]
14. Interindividual variability in the expression and NNK carbonyl reductase activity of 11beta-hydroxysteroid dehydrogenase 1 in human lung.
Soldan M; Nagel G; Losekam M; Ernst M; Maser E
Cancer Lett; 1999 Oct; 145(1-2):49-56. PubMed ID: 10530769
[TBL] [Abstract][Full Text] [Related]
15. The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Maser E; Richter E; Friebertshäuser J
Eur J Biochem; 1996 Jun; 238(2):484-9. PubMed ID: 8681962
[TBL] [Abstract][Full Text] [Related]
16. Sex hormones reduce NNK detoxification through inhibition of short-chain dehydrogenases/reductases and aldo-keto reductases in vitro.
Stapelfeld C; Maser E
Chem Biol Interact; 2017 Oct; 276():167-173. PubMed ID: 28257955
[TBL] [Abstract][Full Text] [Related]
17. 11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine.
Diederich S; Quinkler M; Burkhardt P; Grossmann C; Bähr V; Oelkers W
Eur J Clin Invest; 2000 Dec; 30 Suppl 3():21-7. PubMed ID: 11281363
[TBL] [Abstract][Full Text] [Related]
18. Novel enzymological profiles of human 11beta-hydroxysteroid dehydrogenase type 1.
Hult M; Nobel CS; Abrahmsen L; Nicoll-Griffith DA; Jörnvall H; Oppermann UC
Chem Biol Interact; 2001 Jan; 130-132(1-3):805-14. PubMed ID: 11306096
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of 11beta-hydroxysteroid dehydrogenase type 1/microsomal carbonyl reductase (11beta-HSD/CR) in guinea pig tissues. Purification of the liver form suggests modification in the cosubstrate binding site.
Oppermann UC; Möbus E; Nagel G; Maser E
Toxicology; 2000 Apr; 144(1-3):63-9. PubMed ID: 10781872
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of human type 1 11beta-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics.
Hult M; Jörnvall H; Oppermann UC
FEBS Lett; 1998 Dec; 441(1):25-8. PubMed ID: 9877158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]